Wei-Chou Chang

818 citations
31 papers · 591 indexed · h-index 14
Topics
Hepatocellular Carcinoma Treatment and Prognosis (4 papers)Diabetes Management and Research (3 papers)Antifungal resistance and susceptibility (3 papers)

In The Last Decade

Wei-Chou Chang

31 papers receiving 578 citations

Peers

Wei-Chou Chang
Comparison fields: 5 of 70
  • Epidemiology 255
  • Infectious Diseases 226
  • Endocrinology, Diabetes and Metabolism 112
  • Pulmonary and Respiratory Medicine 105
  • Surgery 94
Replace I. Delèvaux with:
I. Delèvaux France
M Ashour Saudi Arabia
H. Waldner Germany
Charalampos Gogos Greece
José M. Cifrián Spain
Ergün Tozkoparan Türkiye
K. L. N. Rao India
Linjun Xie China
İlhami Uslu Türkiye
Arshad Ali United States
Wei-Chou Chang relative to I. Delèvaux France I. Delèvaux's profile →
Citations per field
00.5×4.3×
I. Delèvaux · 1×
Citations per year

Countries citing papers authored by Wei-Chou Chang

Since Specialization
Citations

This map shows the geographic impact of Wei-Chou Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Chou Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Chou Chang more than expected).

Fields of papers citing papers by Wei-Chou Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Chou Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Chou Chang. The network helps show where Wei-Chou Chang may publish in the future.

Co-authorship network of co-authors of Wei-Chou Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Chou Chang. A scholar is included among the top collaborators of Wei-Chou Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Chou Chang. Wei-Chou Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 7
3 13
4 47
5 9
6 6
7 4
8 5
9 21
10 6
11 4
12 16
13 159
14 12
15 15
16 2
17 32
18 26
19 7
20 30

About Wei-Chou Chang

Wei-Chou Chang is a scholar working on Emergency Medicine, Hepatology and Rheumatology, having authored 31 papers that have together received 591 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Diabetes Management and Research (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Infectious Diseases (226 citations), Epidemiology (255 citations) and Endocrinology, Diabetes and Metabolism (112 citations). Wei-Chou Chang has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Cheng‐Yu Chen, Hsian-He Hsu, Ching Tzao, Ho‐Jui Tung, Shih‐Hung Tsai, Shih-Chun Lee, Kun-Lun Huang, Guo-Shu Huang, Wen-I Liao and Chin-Wang Hsu. Their work appears in journals such as PLoS ONE, Neurology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026